Novel  ||| S:0 E:6 ||| NN
modular  ||| S:6 E:14 ||| NNS
transporters  ||| S:14 E:27 ||| VBP
delivering  ||| S:27 E:38 ||| VBG
anticancer  ||| S:38 E:49 ||| JJ
drugs  ||| S:49 E:55 ||| NNS
and  ||| S:55 E:59 ||| CC
foreign  ||| S:59 E:67 ||| JJ
DNA  ||| S:67 E:71 ||| NN
to  ||| S:71 E:74 ||| TO
the  ||| S:74 E:78 ||| DT
nuclei  ||| S:78 E:85 ||| NN
of  ||| S:85 E:88 ||| IN
target  ||| S:88 E:95 ||| NN
cancer  ||| S:95 E:102 ||| NN
cells  ||| S:102 E:108 ||| NNS
A  ||| S:108 E:110 ||| DT
major  ||| S:110 E:116 ||| JJ
challenge  ||| S:116 E:126 ||| NN
in  ||| S:126 E:129 ||| IN
the  ||| S:129 E:133 ||| DT
development  ||| S:133 E:145 ||| NN
of  ||| S:145 E:148 ||| IN
specific  ||| S:148 E:157 ||| JJ
and  ||| S:157 E:161 ||| CC
effective  ||| S:161 E:171 ||| JJ
cancer  ||| S:171 E:178 ||| NN
treatments  ||| S:178 E:189 ||| NNS
is  ||| S:189 E:192 ||| VBZ
the  ||| S:192 E:196 ||| DT
paradoxical  ||| S:196 E:208 ||| JJ
situation  ||| S:208 E:218 ||| NN
that  ||| S:218 E:223 ||| IN
exploiting  ||| S:223 E:234 ||| VBG
a  ||| S:234 E:236 ||| DT
molecular  ||| S:236 E:246 ||| JJ
target  ||| S:246 E:253 ||| NN
that  ||| S:253 E:258 ||| WDT
is  ||| S:258 E:261 ||| VBZ
accessible  ||| S:261 E:272 ||| JJ
( ||| S:272 E:273 ||| -LRB-
surface  ||| S:273 E:281 ||| NN
membrane  ||| S:281 E:290 ||| NNS
or  ||| S:290 E:293 ||| CC
extracellular  ||| S:293 E:307 ||| JJ
matrix ||| S:307 E:313 ||| NN
)  ||| S:313 E:315 ||| -RRB-
is  ||| S:315 E:318 ||| VBZ
critical  ||| S:318 E:327 ||| JJ
for  ||| S:327 E:331 ||| IN
achieving  ||| S:331 E:341 ||| VBG
tumor  ||| S:341 E:347 ||| NN
selectivity  ||| S:347 E:359 ||| NN
whereas  ||| S:359 E:367 ||| IN
delivery  ||| S:367 E:376 ||| NN
of  ||| S:376 E:379 ||| IN
the  ||| S:379 E:383 ||| DT
therapeutic  ||| S:383 E:395 ||| NN
inside  ||| S:395 E:402 ||| IN
the  ||| S:402 E:406 ||| DT
cell ||| S:406 E:410 ||| NN
,  ||| S:410 E:412 ||| ,
to  ||| S:412 E:415 ||| TO
the  ||| S:415 E:419 ||| DT
cell  ||| S:419 E:424 ||| NN
nucleus  ||| S:424 E:432 ||| NN
is  ||| S:432 E:435 ||| VBZ
generally  ||| S:435 E:445 ||| RB
required  ||| S:445 E:454 ||| VBN
for  ||| S:454 E:458 ||| IN
maximizing  ||| S:458 E:469 ||| VBG
the  ||| S:469 E:473 ||| DT
therapeutic  ||| S:473 E:485 ||| JJ
effect ||| S:485 E:491 ||| NN
.  ||| S:491 E:493 ||| .
Photosensitizers ||| S:493 E:509 ||| NNP
,  ||| S:509 E:511 ||| ,
alpha-particle  ||| S:511 E:526 ||| JJ
emitting  ||| S:526 E:535 ||| JJ
radionuclides  ||| S:535 E:549 ||| NN
and  ||| S:549 E:553 ||| CC
foreign  ||| S:553 E:561 ||| JJ
genetic  ||| S:561 E:569 ||| JJ
material  ||| S:569 E:578 ||| NN
could  ||| S:578 E:584 ||| MD
be  ||| S:584 E:587 ||| VB
considered  ||| S:587 E:598 ||| VBN
as  ||| S:598 E:601 ||| IN
such  ||| S:601 E:606 ||| JJ
therapeutics  ||| S:606 E:619 ||| NN
if  ||| S:619 E:622 ||| IN
they  ||| S:622 E:627 ||| PRP
possessed  ||| S:627 E:637 ||| VBD
cellular  ||| S:637 E:646 ||| JJ
and  ||| S:646 E:650 ||| CC
subcellular  ||| S:650 E:662 ||| JJ
specificity ||| S:662 E:673 ||| NN
.  ||| S:673 E:675 ||| .
The  ||| S:675 E:679 ||| DT
author  ||| S:679 E:686 ||| NN
describes  ||| S:686 E:696 ||| VBZ
a  ||| S:696 E:698 ||| DT
novel  ||| S:698 E:704 ||| NN
approach  ||| S:704 E:713 ||| NN
of  ||| S:713 E:716 ||| IN
using  ||| S:716 E:722 ||| VBG
modular  ||| S:722 E:730 ||| JJ
recombinant  ||| S:730 E:742 ||| JJ
transporters  ||| S:742 E:755 ||| NN
to  ||| S:755 E:758 ||| TO
target  ||| S:758 E:765 ||| VB
the  ||| S:765 E:769 ||| DT
therapeutics  ||| S:769 E:782 ||| NN
to  ||| S:782 E:785 ||| TO
the  ||| S:785 E:789 ||| DT
nucleus  ||| S:789 E:797 ||| NN
of  ||| S:797 E:800 ||| IN
cancer  ||| S:800 E:807 ||| NN
cells ||| S:807 E:812 ||| NNS
,  ||| S:812 E:814 ||| ,
where  ||| S:814 E:820 ||| WRB
their  ||| S:820 E:826 ||| PRP$
action  ||| S:826 E:833 ||| NN
is  ||| S:833 E:836 ||| VBZ
most  ||| S:836 E:841 ||| RBS
pronounced  ||| S:841 E:852 ||| JJ
or  ||| S:852 E:855 ||| CC
can  ||| S:855 E:859 ||| MD
only  ||| S:859 E:864 ||| RB
be  ||| S:864 E:867 ||| VB
expressed ||| S:867 E:876 ||| VBN
.  ||| S:876 E:878 ||| .
Photo-sensitizer-transporter  ||| S:878 E:907 ||| JJ
conjugates  ||| S:907 E:918 ||| NN
displayed  ||| S:918 E:928 ||| VBD
up  ||| S:928 E:931 ||| RP
to  ||| S:931 E:934 ||| TO
3000  ||| S:934 E:939 ||| CD
times  ||| S:939 E:945 ||| NNS
greater  ||| S:945 E:953 ||| JJR
efficacy  ||| S:953 E:962 ||| NN
than  ||| S:962 E:967 ||| IN
free  ||| S:967 E:972 ||| JJ
photosensitizers  ||| S:972 E:989 ||| NN
and  ||| S:989 E:993 ||| CC
acquired  ||| S:993 E:1002 ||| VBN
cell  ||| S:1002 E:1007 ||| NN
specificity  ||| S:1007 E:1019 ||| NN
in  ||| S:1019 E:1022 ||| IN
contrast  ||| S:1022 E:1031 ||| NN
to  ||| S:1031 E:1034 ||| TO
free  ||| S:1034 E:1039 ||| JJ
photosensitizers ||| S:1039 E:1055 ||| NN
.  ||| S:1055 E:1057 ||| .
Alpha-emitting  ||| S:1057 E:1072 ||| JJ
radionuclides ||| S:1072 E:1085 ||| NN
,  ||| S:1085 E:1087 ||| ,
conjugated  ||| S:1087 E:1098 ||| VBG
with  ||| S:1098 E:1103 ||| IN
the  ||| S:1103 E:1107 ||| DT
modular  ||| S:1107 E:1115 ||| JJ
transporters ||| S:1115 E:1127 ||| NN
,  ||| S:1127 E:1129 ||| ,
acquired  ||| S:1129 E:1138 ||| VBD
similar  ||| S:1138 E:1146 ||| JJ
properties ||| S:1146 E:1156 ||| NNS
.  ||| S:1156 E:1158 ||| .
DNA  ||| S:1158 E:1162 ||| NNP
complexed  ||| S:1162 E:1172 ||| NN
with  ||| S:1172 E:1177 ||| IN
analogous  ||| S:1177 E:1187 ||| JJ
transporters  ||| S:1187 E:1200 ||| NNS
efficiently  ||| S:1200 E:1212 ||| RB
transfected  ||| S:1212 E:1224 ||| JJ
target  ||| S:1224 E:1231 ||| NN
cells ||| S:1231 E:1236 ||| NNS
.  ||| S:1236 E:1238 ||| .
The  ||| S:1238 E:1242 ||| DT
different  ||| S:1242 E:1252 ||| JJ
modules  ||| S:1252 E:1260 ||| NN
of  ||| S:1260 E:1263 ||| IN
the  ||| S:1263 E:1267 ||| DT
transporters  ||| S:1267 E:1280 ||| NNS
are  ||| S:1280 E:1284 ||| VBP
interchangeable ||| S:1284 E:1299 ||| VBN
,  ||| S:1299 E:1301 ||| ,
meaning  ||| S:1301 E:1309 ||| VBG
that  ||| S:1309 E:1314 ||| IN
they  ||| S:1314 E:1319 ||| PRP
can  ||| S:1319 E:1323 ||| MD
be  ||| S:1323 E:1326 ||| VB
tailored  ||| S:1326 E:1335 ||| VBN
for  ||| S:1335 E:1339 ||| IN
particular  ||| S:1339 E:1350 ||| JJ
applications ||| S:1350 E:1362 ||| NNS
.  ||| S:1362 E:1364 ||| .
